Zhejiang Jolly Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of March 2024: 0.03%

Zhejiang Jolly Pharmaceutical Co Ltd asset resilience ratio. Zhejiang Jolly Pharmaceutical Co Ltd (300181) has an Asset Resilience Ratio of 0.03% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhejiang Jolly Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.00 Million
≈ $146.33K USD Cash + Short-term Investments

Total Assets

CN¥3.86 Billion
≈ $565.52 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Zhejiang Jolly Pharmaceutical Co Ltd (2015–2023)

Asset resilience ratio of Zhejiang Jolly Pharmaceutical Co Ltd from 2015 to 2023. This chart shows how Zhejiang Jolly Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 300181 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Jolly Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 300181 current and non-current assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.00 Million 0.03%
Total Liquid Assets CN¥1.00 Million 0.03%

Asset Resilience Insights

  • Limited Liquidity: Zhejiang Jolly Pharmaceutical Co Ltd maintains only 0.03% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Jolly Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Jolly Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Merck & Company Inc
NYSE:MRK
Drug Manufacturers - General 0.22%
AstraZeneca PLC
NASDAQ:AZN
Drug Manufacturers - General 0.10%
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 5.33%
Novartis AG
MX:NVSN
Drug Manufacturers - General 0.08%
Pfizer Inc
NYSE:PFE
Drug Manufacturers - General 5.33%
Novo Nordisk A/S
CO:NOVO-B
Drug Manufacturers - General 0.09%
Zhejiang Int'L Group Co Ltd
SHE:000411
Drug Manufacturers - General 0.00%
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR
Drug Manufacturers - General 0.07%

Zhejiang Jolly Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2015–2023)

Zhejiang Jolly Pharmaceutical Co Ltd asset resilience ratio by year from 2015 to 2023. The table below shows the annual Asset Resilience Ratio data for Zhejiang Jolly Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 4.16% CN¥151.00 Million
≈ $22.10 Million
CN¥3.63 Billion
≈ $530.75 Million
+3.87pp
2022-12-31 0.30% CN¥10.83 Million
≈ $1.58 Million
CN¥3.64 Billion
≈ $532.52 Million
-2.09pp
2021-12-31 2.38% CN¥65.52 Million
≈ $9.59 Million
CN¥2.75 Billion
≈ $402.20 Million
-0.09pp
2020-12-31 2.47% CN¥61.04 Million
≈ $8.93 Million
CN¥2.47 Billion
≈ $361.42 Million
+2.46pp
2019-12-31 0.01% CN¥300.00K
≈ $43.90K
CN¥2.05 Billion
≈ $300.07 Million
-0.14pp
2018-12-31 0.15% CN¥3.19 Million
≈ $466.49K
CN¥2.11 Billion
≈ $309.32 Million
-4.77pp
2017-12-31 4.92% CN¥106.00 Million
≈ $15.51 Million
CN¥2.15 Billion
≈ $314.97 Million
-2.51pp
2016-12-31 7.43% CN¥151.50 Million
≈ $22.17 Million
CN¥2.04 Billion
≈ $298.20 Million
-4.41pp
2015-12-31 11.84% CN¥219.13 Million
≈ $32.07 Million
CN¥1.85 Billion
≈ $270.79 Million
--
pp = percentage points

About Zhejiang Jolly Pharmaceutical Co Ltd

SHE:300181 China Drug Manufacturers - General
Market Cap
$1.29 Billion
CN¥8.82 Billion CNY
Market Cap Rank
#7626 Global
#1641 in China
Share Price
CN¥12.57
Change (1 day)
+1.13%
52-Week Range
CN¥12.00 - CN¥18.45
All Time High
CN¥20.53
About

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kid… Read more